Harvard Management Company’s Maze Therapeutics, Inc. Common Stock MAZE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.82M Hold
637,528
0.54% 12
2025
Q1
$7.02M Buy
+637,528
New +$7.02M 0.62% 12